This bill reauthorizes and updates federal vector-borne disease initiatives and grant programs through 2030 to improve the prevention, identification, and response to tick-borne illnesses.
Christopher "Chris" Smith
Representative
NJ-4
The Kay Hagan Tick Act reauthorization extends federal funding and support for vector-borne disease initiatives through 2030. This legislation updates national strategy requirements and enhances the capacity of regional centers and health departments to identify, prevent, and respond to tick-borne and other vector-borne illnesses.
The Kay Hagan Tick Act is getting a major tune-up and a five-year extension, pushing its programs out to 2030. If you’ve ever found a tick on your leg after a hike or worried about West Nile virus in your backyard, this bill is the primary engine behind how the U.S. tracks and fights those threats. It specifically reauthorizes funding for regional centers of excellence and provides a steady stream of grants to local health departments, ensuring the people on the front lines of bug-borne illnesses have the tools to stay ahead of the next outbreak.
One of the biggest shifts in this update is a new focus on "capacity building" for regional centers of excellence. Under Section 317U, these centers are being tasked with getting better at the basics: identifying, reporting, and preventing diseases spread by vectors (that’s science-speak for ticks, mosquitoes, and fleas). For a construction worker in the Northeast or a landscaper in the South, this means the data tracking where Lyme disease or Zika is spreading should become more accurate and timely. The bill moves the goalposts from simply having these centers to ensuring they are actively improving their response times and reporting accuracy through the end of the decade.
The bill also changes how the government draws up its battle plan. Previously, the national strategy for vector-borne diseases had to be developed alongside the Tick-Borne Disease Working Group—a specific body of experts and stakeholders. The new language in Section 1 swaps that requirement for consultation with "appropriate individuals." While this sounds like standard bureaucratic cleanup to allow for more flexibility, it’s a bit of a vague shift. It essentially gives the government more leeway in who they listen to when setting priorities, which could be great for efficiency but might also mean less direct input from the specific patient advocacy groups that the original working group was designed to include.
For the average person, the most visible part of this bill is the extension of grants for local health departments under Section 2822(c). These are the folks who actually do the mosquito spraying in your neighborhood or run public awareness campaigns about how to spot a deer tick. By locking in this authorization from 2026 through 2030, the bill provides a level of financial predictability for local governments. It’s a move to ensure that just because a specific disease isn't making headlines this week, the infrastructure to catch it before it becomes a crisis doesn't disappear.